E-LIB Suche - Ergebnisse für: Metro, G.

1

91P Observational retro-prospective study on immune checkpo..:

Gemelli, M. ; Sala, E. ; Trevisan, B....
ESMO Open. 9 (2024) - p. 102670 , 2024

Link: https://doi.org/10.1016/..

2

52P Liquid biopsy monitoring in BRAF V600E mutated NSCLC pa..:

Leonetti, A. ; Minari, R. ; Pluchino, M....
ESMO Open. 9 (2024) - p. 102631 , 2024

Link: https://doi.org/10.1016/..

3

140P New inflammatory biomarkers in uresectable stage III N..:

Olmetto, E. ; Mattioli, C. ; Caini, S....
ESMO Open. 9 (2024) - p. 102727 , 2024

Link: https://doi.org/10.1016/..

4

P2.05-02 MAPK1/MAPK3 Mutations Enhance Immunotherapy Effica..:

Cappuzzo, F. ; Fusco, F. ; Bonanno, L....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S307 , 2023

Link: https://doi.org/10.1016/..

5

PP01.17 Sotorasib in Advanced KRAS p.G12C–Mutated NSCLC wit..:

Awad, M.M. ; Pelizzari, G. ; Stevenson, J....
Journal of Thoracic Oncology. 18 (2023) 3 - p. e17 , 2023

Link: https://doi.org/10.1016/..

6

P1.22-19 Determination of the Membranous Expression of cMET..:

Marinello, A. ; Ghigna, M.R. ; Mandarano, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S253-S254 , 2023

Link: https://doi.org/10.1016/..

7

EP08.01-030 Nivolumab+Ipilimumab Vs Platinum-Based CT+Nivol..:

Delmonte, A. ; Bonanno, L. ; Landi, L....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S351 , 2022

Link: https://doi.org/10.1016/..

8

EP08.02-060 How Do Oncologists Treat Patients With EGFR Exo..:

Mountzios, G. ; Planchard, D. ; Metro, G....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S427-S428 , 2022

Link: https://doi.org/10.1016/..

9

EP02.04-001 Alectinib as Neoadjuvant Treatment in Surgicall..:

Leonetti, A. ; Minari, R. ; Boni, L....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S231 , 2022

Link: https://doi.org/10.1016/..

10

EP08.02-140 MET Biomarker-based Preliminary Efficacy Analys..:

Ahn, M-j. ; De Marinis, F. ; Bonanno, L....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S469-S470 , 2022

Link: https://doi.org/10.1016/..

11

Molecular characterization of primary and secondary resista..:

Marinello, A. ; Vasseur, D. ; Conci, N....
European Journal of Cancer. 174 (2022) - p. S26 , 2022

Link: https://doi.org/10.1016/..

12

EP08.02-046 Activity of OsimeRTInib in NSCLC with Uncommon ..:

Pizzutilo, E.G. ; Agostara, A.G. ; Oresti, S....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S418-S419 , 2022

Link: https://doi.org/10.1016/..

13

Upfront pembrolizumab as an effective treatment start in pa..:

Metro, G. ; Gili, A. ; Signorelli, D....
Clinical and Translational Oncology. 23 (2021) 9 - p. 1818-1826 , 2021

Link: https://doi.org/10.1007/..

14

Baseline neutrophil-to-lymphocyte ratio and PD-L1 expressio..:

Banna, G. ; Signorelli, D. ; Metro, G....
Lung Cancer. 139 (2020) - p. S58-S59 , 2020

Link: https://doi.org/10.1016/..

15

Clinical outcomes to pemetrexed-based versus non-pemetrexed..:

Ricciuti, B. ; Brambilla, M. ; Cortellini, A....
Clinical and Translational Oncology. 22 (2019) 5 - p. 708-716 , 2019

Link: https://doi.org/10.1007/..